Showing results (101-110 of 151) with videos related to

Sort By:
Pageof 16
Cells|October 23, 2021
Integrated CGH/WES Analyses Advance Understanding of Aggressive Neuroblastoma Evolution: A Case StudyDiana Corallo, Carlo Zanon, Marcella Pantile, et al.
British Journal of Haematology|September 15, 2009
Absence of VOD in paediatric thalassaemic HSCT recipients using defibrotide prophylaxis and intravenous BusulphanBarbara Cappelli, Robert Chiesa, Costanza Evangelio, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 10, 2019
Hematopoietic Stem Cell Transplantation to Treat Leukodystrophies: Clinical Practice Guidelines from the Hunter's Hope Leukodystrophy Care NetworkKristin M Page, Elizabeth O Stenger, James A Connelly, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 8, 2009
Unpredictability of intravenous busulfan pharmacokinetics in children undergoing hematopoietic stem cell transplantation for advanced beta thalassemia: limited toxicity with a dose-adjustment policyRobert Chiesa, Barbara Cappelli, Roberto Crocchiolo, et al.
Blood Advances|October 5, 2018
Successful hematopoietic stem cell mobilization and apheresis collection using plerixafor alone in sickle cell patientsErica B Esrick, John P Manis, Heather Daley, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 4, 2024
An empowered, clinically viable hematopoietic stem cell gene therapy for the treatment of multisystemic mucopolysaccharidosis type IISabyasachi Das, Fatlum Rruga, Annita Montepeloso, et al.
Molecular Therapy. Methods & Clinical Development|May 3, 2019
Pre-clinical Safety and Efficacy of Lentiviral Vector-Mediated <i>Ex Vivo</i> Stem Cell Gene Therapy for the Treatment of Mucopolysaccharidosis IIIAStuart M Ellison, Aiyin Liao, Shaun Wood, et al.
Blood|March 16, 2011
Lentiviral vector common integration sites in preclinical models and a clinical trial reflect a benign integration bias and not oncogenic selectionAlessandra Biffi, Cynthia C Bartolomae, Daniela Cesana, et al.
Frontiers in Oncology|June 11, 2021
Low miR-214-5p Expression Correlates With Aggressive Subtypes of Pediatric ALCL With Non-Common HistologyPiero Di Battista, Federica Lovisa, Enrico Gaffo, et al.
Annals of Clinical Microbiology and Antimicrobials|February 15, 2024
Application of the Weighted-Incidence Syndromic Combination Antibiogram (WISCA) to guide the empiric antibiotic treatment of febrile neutropenia in oncological paediatric patients: experience from two paediatric hospitals in Northern ItalyCecilia Liberati, Daniele Donà, Linda Maestri, et al.
Pageof 16